. . . . . . . "[These trials have provided evidence suggesting safety of the anti-IGF-I receptor antibodies, a few anecdotes of impressive single-agent activity, and early evidence for a significant improvement in response rate to chemotherapy for lung cancer with co-administration of an anti-IGF-I receptor antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:39+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .